Beta Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results
Beta Drugs Ltd 路 Intimation 路 22 Oct 2026, 5:30 am
Beta Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results Beta Drugs Ltd. announced that its Board of Directors will meet on 22nd Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for designated persons and their immediate relatives has been closed effective 1st Oct'26 and will remain closed until 24th Oct'26, 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Beta Drugs Ltd
- BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 19-Nov-2026 to consider Other business. 路 16 Nov 2026
- To consider other business matters 路 16 Nov 2026
- Monitoring Agency Report as on 30th September, 2026 路 12 Nov 2026
- Beta Drugs Limited has informed the Exchange about Transcript 路 28 Oct 2026
- Beta Drugs Limited has informed the Exchange about Link of Recording 路 22 Oct 2026
- Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 22 Oct 2026
- Beta Drugs Limited has informed the Exchange about Presentation 路 22 Oct 2026
- Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 22 Oct 2026
